HOME >> BIOLOGY >> NEWS
Protein stops blood-vessel growth, holds promise as cancer therapy

Researchers at National Jewish Medical and Research Center have identified a protein that inhibits the formation of new blood vessels.

Combined with previous findings that the protein is depleted or missing in a majority of metastatic human cancers, the findings suggest that fibulin-5 may one day be an effective cancer therapy. William Schiemann, Ph.D., Assistant Professor in the Program in Cell Biology at National Jewish, and postdoctoral fellow Allan R. Albig reported their findings in the June issue of DNA and Cell Biology.

"We believe fibulin-5 shows real promise as a cancer therapy," said Schiemann. "When we slightly altered the naturally occurring protein it was even more effective at inhibiting the sprouting of new blood vessels."

Cancer tumors need nutrients and oxygen supplied by blood vessels in order to grow. They also use blood vessels to spread to other parts of the body.

This process, known as metastasis, is the most lethal characteristic of cancer and the leading cause of cancer-related death. The strategy of fighting cancer by preventing the growth of new blood vessels has generated great interest in recent years, with the first antiangiogenic drug being approved earlier this year.

Endothelial cells have been the target of most antiangiogenic strategies. Endothelial cells are specialized cells that develop into blood vessels. Fibulin-5, a member of a family of extracellular matrix proteins that regulate tissue development, remodeling and repair, interacts with endothelial cells.

In cell culture studies, Schiemann and Albig showed fibulin-5 levels drop significantly when endothelial cells begin to form blood vessels, a process known as tubulation. They also show that high levels of fibulin-5 could prevent the sprouting of new blood vessels by inhibiting the proliferation and movement of endothelial cells.

Fibulin-5 interfered with signaling by the proangiogenic factor VEGF, and increased level
'"/>

Contact: William Allstetter
allstetterw@njc.org
303-398-1002
National Jewish Medical and Research Center
18-Jun-2004


Page: 1 2

Related biology news :

1. Protein is key to fatal disorder and normal cell function
2. Protein is key for digestive function of the pancreas
3. Proteins show promise for mosquito control
4. Protein involved in childhood disorder linked to cancer
5. Protein fishing in America: The movie
6. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
7. Protein key to trafficking in nerve terminals
8. Protein controls acid in cells by direct detection of volume changes, study finds
9. Protein believed to control formation of memory identified by Scripps & UCSD scientists
10. Proteins transform DNA into molecular velcro
11. Protein engineered to detect nerve gas

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 23, 2020 , ... ... antibody development services, today announced that the company has received ISO9001:2015 certification ... pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation demonstrates ...
(Date:6/23/2020)... ... June 23, 2020 , ... Rigaku Corporation , ... event in a series of TOPIQ webinars, which will cover the Transferable Aspherical ... developed in response to social distancing measures that resulted in postponements and cancelations ...
(Date:6/19/2020)... ... June 18, 2020 , ... ... for Data Decisions,” for pharmaceutical and biotech executives, laboratory managers, scientists, researchers ... scientific instruments and laboratory equipment from dozens of manufacturers into their lab. ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... 29, 2020 , ... Anomet Products has introduced new custom ... use with CRM, neurostimulation, vascular, and related devices. , Anomet Medical Clad ... performance, and cost criteria; especially where solid wire is limited. Typical configurations for ...
(Date:7/22/2020)... , ... July 22, 2020 , ... Join experts from ... Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar on ... regulating body in China for drugs and medical devices. Specifically, for medical devices, the ...
(Date:7/10/2020)... ... July 08, 2020 , ... ... a significant expansion of laboratory operations through its COVID-19 testing service, Bode-CARES ... programs. , Bode-CARES provides a turnkey solution that includes a ...
(Date:7/7/2020)... ... July 06, 2020 , ... Bio-IT World has announced ... Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the ... awards program, highlighting outstanding examples of how technology innovations and strategic initiatives can ...
Breaking Biology Technology:
Cached News: